Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes by delivering the most advanced radiomics and AI-enabled, lung cancer decision support software. Formerly Mindshare Medical. Investor since 2016.
Location: United States, Washington, Seattle
Employees: 1-10
Founded date: 2014
Investors 1
| Date | Name | Website |
| 10.03.2022 | Westway Ca... | westwaycap... |
Mentions in press and media 5
| Date | Title | Description |
| 07.08.2026 | RevealDx Received $3.4M Investment From 4DMedical | RevealDx, a Seattle, WA-based provider of medical imaging AI software for lung nodule characterization, received a $3.4M investment from 4DMedical. The company intends to use the funds to expand access to its flagship product, RevealAI-Lung... |
| 05.08.2026 | 4DMedical Invests $3.4M in RevealDx to Build a Connected Cardiopulmonary Platform | What You Should Know Seattle-based RevealDx has secured a $3.4M strategic investment and a global distribution agreement with Melbourne-listed 4DMedical. The agreement appoints 4DMedical as the distributor for RevealDx’s flagship software, ... |
| 23.10.2025 | How AI Is Poised to Cut Lung Cancer Mortality by Accelerating Early Detection | Chris Wood, CEO of Reveal Dx With lung cancer being the leading cause of cancer-related deaths worldwide, advancements in AI-powered healthcare technology are offering newfound hope. Over the span of the next few decades, AI is poised to re... |
| 02.05.2024 | contextflow targets early lung cancer detection by augmenting ADVANCE Chest CT with malignancy scoring from RevealDX | Malignancy Scoring can reduce false positives and detect lung cancer up to one year sooner. contextflow and RevealDx are working to improve lung cancer screening Chest CT experts contextflow GmbH have released a new version of their compreh... |
| - | Reveal-Dx | “Reveal DX | Informing Precision Medicine” |